Circulating miR-497 and miR-663b in plasma are potential novel biomarkers for bladder cancer
MicroRNAs (miRNAs), abundant and highly stable in the plasma, have been widely reported. This greatly pursued us to investigate whether plasma miRNAs could be considered as powerful biomarkers for diagnosing bladder cancer (BC). We performed a plasma miRNAs profile with the TaqMan Low Density Array,...
Main Authors: | Du, Mulong, Shi, Danni, Yuan, Lin, Li, Pengchao, Chu, Haiyan, Qin, Chao, Yin, Changjun, Zhang, Zhengdong, Wang, Meilin |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444850/ |
Similar Items
-
Genetic Variation in DROSHA 3’UTR Regulated by hsa-miR-27b Is Associated with Bladder Cancer Risk
by: Yuan, Lin, et al.
Published: (2013) -
Clinical impact of circulating miR-133, miR-1291 and miR-663b in plasma of patients with acute myocardial infarction
by: Peng, Liu, et al.
Published: (2014) -
Circulating miR-583 and miR-663 Refer to ZHENG Differentiation in Chronic Hepatitis B
by: Zhang, Hui, et al.
Published: (2013) -
Serum miRNAs panel (miR-16-2*, miR-195, miR-2861, miR-497) as novel non-invasive biomarkers for detection of cervical cancer
by: Zhang, Yujuan, et al.
Published: (2015) -
Fluoxetine Increases the Expression of miR-572 and miR-663a in Human Neuroblastoma Cell Lines
by: Mundalil Vasu, Mahesh, et al.
Published: (2016)